82 ANTI-POLLUTION A
B UPM ■ H-EPS ■ 500 400 300 200 ** 100 ** 0 2h Treatment time (h) 24h * p<0.05 ** p<0.01
Figure 1: Effect of H-EPS and UPM on NRF2 activation. A. Nuclear translocation of NRF2 in keratinocytes treated with either H-EPS or UPM. B. Quantification of NRF2 translocation in keratinocytes treated with H-EPS or UPM for two hours and 24 hours
TABLE 1: EFFECT OF POLLUTION IN MITOCHONDRIAL METABOLISM. THREE PARAMETERS WERE STUDIED: MITOCHONDRIAL MEMBRANE POTENTIAL; O2 CONSUMPTION AND ATP PRODUCTION
Mitochondrial membrane potential 590/520
Ratio (x10-5 per 104
Control UPM
15,52 ± 2,49
4,34 ± 0,90 ) cells Reference -72% p<0,01
1,28 ± 0,14
0,90 ± 0,09 Reference -30% p<0.01 % Change pO2 O2 consumption / minute % Change (nM/106 cell.) % Change ATP
3410 ± 149
2703 ± 168
Reference -21% p<0.01
TABLE 2: EFFECT OF H-EPS ON MITOCHONDRIAL METABOLISM. EFFECT WAS STUDIED IN KERATINOCYTES AND IN THE POLLUTION MODEL
Mitochondrial membrane potential 590/520
Ratio (x10-5 per 104
Control (vehicle)
H-EPS
Control (UPM)
UPM +
H-EPS
12,66 ± 1,34
16,86 ± 2,38
4,34 ± 0,90
6,50 ± 1,26
) cells Reference +33% p<0,01 Reference +50% p<0,01
1,28 ± 0,14
1,59
± 0,20 0,90
± 0,09 1,12
± 0,13 Reference +24% p<0.05 Reference +24% p<0,01 % Change pO2 O2 consumption / minute % Change (nM/106 cell.) % Change ATP
3410 ± 149
6269 ± 778
2703 ± 168
4701 ± 267
Reference +84% p<0,01 Reference +74% p<0,01 ATP production ATP production
NRF2 activation assay HaCaT cells were seeded in 8-compartment glass slides (Labtech) in DMEM medium (Gibco). After 3 days, cells were treated with H-EPS and/ or BaP (benzo[a]pyrene) for up to 24 hours. Cell treatment was stopped at different time points. Cells were then fixed in formaldehyde and immuno-stained for NRF2. NRF2 quantity in the nuclei was determined. Cell density was determined by Hoechst 33258 staining.
Skin treatments Equivalent skin models were produced in-house as described previously. Briefly, for equivalent-dermis, fibroblasts were seeded into collagen-I matrix (Jacques Boy) in six-well plate inserts (Falcon) and kept emerged for 48 hours for dermal contraction. Normal Human keratinocytes (Cellntec) were seeded on top of the equivalent dermis. Models were cultivated for seven days in immersion medium, followed by seven days of air-liquid interphase to obtain a stratified epidermis. H-EPS and/ or UPM were topically applied
for 48 hours. Skins were embedded in freezing media (Leica,) and snap-frozen in liquid nitrogen. 5-7 µm sections were prepared using a cryostat (Leica). Histology was evaluated by H&E (Sigma-
PERSONAL CARE MAGAZINE May 2026
www.personalcaremagazine.com * **
manufacturer’s instruction. Cells were fixed in histochoice (Interchim) and nuclei number was determined by Hoechst 33258 staining. ATP levels were normalized to cell number.
Oxygen consumption HaCaT cells were seeded in T25 cell flasks (Falcon) in DMEM medium (Gibco). After 48 hours, cells were treated with H-EPS and/ or UPM. The next day cells were detached and added to OxoPlates (PreSens). The medium was covered by a layer of oil
to avoid oxygen exchange with the external environment. Oxygen levels were quantified using fluorescent probe (Ex 540 nm / Em: 650 nm). Oxygen consumption rates were quantified with time.
Quantification of ROS levels HaCaTs cells were seeded in 96 well plates in DMEM medium (Gibco). The next day cells were treated with H-EPS and/or UPM for 4 h. Cells were rinsed with HBSS (Invitrogen) and stained with the CM-H2DCFDA (Invitrogen) probe for 45 minutes. Fluorescence signals were quantified using
ImageXpress (Molecular Devices) (Ex / Em : ∼492–495/517–527 nm). Cells were then fixed in formaldehyde (Sigma-Aldrich) and nuclei number was determined using Hoechst 33258 staining.
NRF2 translocation level (%)
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100